New England Congenital Cardiology Research Foundation (EIN 800368043) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2009

Legal Domicile

Principal Officer

David W Brown MD

Phone

6173556800

Tax Period

2023-10-01 to 2024-09-30

New England Congenital Cardiology Research Foundation, founded in 2009, is a small nonprofit in the Health Care sector that reported $101K in total revenue in fiscal year 2023. Revenue surged 85% from the prior year, signaling strong growth momentum. Expenses of $90K left a modest 11% surplus.

Mission

Sponsor research programs to improve patient safety and quality for children with heart disease

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $35,600

Program Service Revenue $0

Investment Income $65,895

Other Revenue $0

TOTAL REVENUE $101,495

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $51,918

Other Expenses $90,355

TOTAL EXPENSES $90,355

Year-over-Year Comparison

	2023	2022	Change
Revenue	$101,495	$54,855	+0.9%
Expenses	$90,355	$60,685	+0.5%
Net Income	$11,140	$-5,830	-2.9%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
David W Brown MD	Treasurer & Trustee	5.00	Officer Director	$0	$0	$0
Brooke Davey MD	Trustee	5.00	Director	$0	$0	$0
Robert Elder MD	Clerk & Trustee	5.00	Officer Director	$0	$0	$0
Jonathan Flyer MD	President & Trustee	5.00	Officer Director	$0	$0	$0
Naomi S Gauthier MD	Vice President & Trustee	5.00	Officer Director	$0	$0	$0
David Kane MD	Trustee	5.00	Director	$0	$0	$0
Thomas Miller MD	Trustee	5.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$101,495	$90,355	$1,437,207	$11,140
2023	$54,855	$60,685	$1,315,848	$-5,830
2022	$53,729	$41,508	$1,268,938	$12,221
2021	$29,353	$54,691	$1,417,251	$-25,338
2020	$24,200	$31,173	$1,212,282	$-6,973

New England Congenital Cardiology Research Foundation